CA2859927A1 - Empreinte genetique gcg et profil clhp - Google Patents
Empreinte genetique gcg et profil clhp Download PDFInfo
- Publication number
- CA2859927A1 CA2859927A1 CA2859927A CA2859927A CA2859927A1 CA 2859927 A1 CA2859927 A1 CA 2859927A1 CA 2859927 A CA2859927 A CA 2859927A CA 2859927 A CA2859927 A CA 2859927A CA 2859927 A1 CA2859927 A1 CA 2859927A1
- Authority
- CA
- Canada
- Prior art keywords
- cultivar
- strain
- profile
- cannabis
- thc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002068 genetic effect Effects 0.000 title claims abstract description 14
- UCONUSSAWGCZMV-HZPDHXFCSA-N Delta(9)-tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 claims abstract description 50
- 229930003827 cannabinoid Natural products 0.000 claims abstract description 36
- 239000003557 cannabinoid Substances 0.000 claims abstract description 36
- 238000001502 gel electrophoresis Methods 0.000 claims abstract description 7
- 241000218236 Cannabis Species 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 32
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 18
- 239000012634 fragment Substances 0.000 claims description 16
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims description 14
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims description 12
- 229950011318 cannabidiol Drugs 0.000 claims description 12
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims description 12
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims description 12
- 208000000094 Chronic Pain Diseases 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 8
- 208000002193 Pain Diseases 0.000 claims description 8
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims description 8
- 238000010367 cloning Methods 0.000 claims description 8
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 8
- 229960004242 dronabinol Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 206010015037 epilepsy Diseases 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 229940065144 cannabinoids Drugs 0.000 claims description 6
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 claims description 4
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 claims description 4
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 claims description 4
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 claims description 4
- ZLHQMHUXJUPEHK-UHFFFAOYSA-N Cannabivarin Natural products CCCc1cc(O)c2c(OC(C)(C)c3ccccc23)c1 ZLHQMHUXJUPEHK-UHFFFAOYSA-N 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 4
- 239000005557 antagonist Substances 0.000 claims description 4
- 230000011681 asexual reproduction Effects 0.000 claims description 4
- 238000013465 asexual reproduction Methods 0.000 claims description 4
- SVTKBAIRFMXQQF-UHFFFAOYSA-N cannabivarin Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCC)C=C3OC(C)(C)C2=C1 SVTKBAIRFMXQQF-UHFFFAOYSA-N 0.000 claims description 4
- 208000037976 chronic inflammation Diseases 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 230000004054 inflammatory process Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000000877 morphologic effect Effects 0.000 claims description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 4
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 abstract description 6
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 abstract description 6
- YOVRGSHRZRJTLZ-UHFFFAOYSA-N Delta9-THCA Natural products C1=C(C(O)=O)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 YOVRGSHRZRJTLZ-UHFFFAOYSA-N 0.000 abstract description 3
- UCONUSSAWGCZMV-UHFFFAOYSA-N Tetrahydro-cannabinol-carbonsaeure Natural products O1C(C)(C)C2CCC(C)=CC2C2=C1C=C(CCCCC)C(C(O)=O)=C2O UCONUSSAWGCZMV-UHFFFAOYSA-N 0.000 abstract description 3
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 abstract description 3
- 240000004308 marijuana Species 0.000 abstract 1
- 208000014797 chronic intestinal pseudoobstruction Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/12—Leaves
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2859927A CA2859927A1 (fr) | 2014-09-22 | 2014-09-22 | Empreinte genetique gcg et profil clhp |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2859927A CA2859927A1 (fr) | 2014-09-22 | 2014-09-22 | Empreinte genetique gcg et profil clhp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2859927A1 true CA2859927A1 (fr) | 2016-03-22 |
Family
ID=55539871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2859927A Abandoned CA2859927A1 (fr) | 2014-09-22 | 2014-09-22 | Empreinte genetique gcg et profil clhp |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2859927A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3896176A1 (fr) * | 2020-04-17 | 2021-10-20 | Krei Method S.L. | Procédé pour la détermination de l'empreinte digitale dans les variétés de cannabis |
-
2014
- 2014-09-22 CA CA2859927A patent/CA2859927A1/fr not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3896176A1 (fr) * | 2020-04-17 | 2021-10-20 | Krei Method S.L. | Procédé pour la détermination de l'empreinte digitale dans les variétés de cannabis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2859934A1 (fr) | Comete de hayley ii | |
| CA2737447A1 (fr) | "hayley's comet" | |
| de Paulo Pereira et al. | Polysaccharide fractions of Caesalpinia ferrea pods: potential anti-inflammatory usage | |
| Mikulic-Petkovsek et al. | Investigation of anthocyanin profile of four elderberry species and interspecific hybrids | |
| Almeida et al. | Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain | |
| JP6741581B2 (ja) | オリーブからの液体植物複合体の抗炎症使用 | |
| BR112018010617A2 (pt) | processos para recuperação de produtos a partir de um mingau de fermentação de milho | |
| BR112017010110A2 (pt) | anticorpos contra cd73 e usos do mesmo | |
| WO2010036965A3 (fr) | Marqueurs génétiques d'endophénotypes de la schizophrénie | |
| TN2017000081A1 (fr) | Extrait d'algues concentré, procédé de préparation et ses utilisations en agriculture. | |
| Galstian et al. | The results of the Russian clinical trial of mesenchymal stromal cells (MSCs) in severe neutropenic patients (pts) with septic shock (SS)(RUMCESS trial) | |
| FR3064638B1 (fr) | Nouveau gelifiant polyurethane | |
| BR112018072235A2 (pt) | formulações e métodos para tratar organismos fotossintéticos e aumentar as qualidades e quantidades das produções com formulações de compósitos de glicano | |
| JP2017501209A (ja) | オリーブからの液体植物複合体の抗血管新生使用 | |
| Krishna et al. | Micropropagation of lasora (Cordia myxa Roxb.) | |
| CA2859927A1 (fr) | Empreinte genetique gcg et profil clhp | |
| Hajrah et al. | Gene expression profiling to elucidate the pharmacological and toxicological effects of Ricinus communis L. leaf extract in mammalian cells | |
| RU2020119597A (ru) | Композиция для лечения пациента с респираторным заболеванием, обусловленным хроническим воспалением, способ получения и применение указанной композиции | |
| WO2017220044A3 (fr) | Composition pharmaceutique de bifonazole et son effet de protection du foie | |
| CN205681888U (zh) | 灌木割台装置 | |
| Fahaid H et al. | Increased systemic low-grade inflammation in high altitude native rats mediated by adrenergic receptors | |
| Belchior et al. | Costs and economic viability in charcoal production in the state of Mato Grosso do Sul. | |
| FR3089759B1 (fr) | Extrait hydrosoluble et procédé d’obtention à partir de cuticules d’insectes | |
| Bharathi et al. | Estimation of capsaicin and capsaicinoid contents of high pungent chilli accessions of Andaman & Nicobar Islands and North-East India | |
| Bizari et al. | Diferentes sistemas de manejo do solo no consumo de água do feijoeiro irrigado em Campinas-SP |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20170413 |